Editorial Commentary: Should "heterogeneous response" be considered as new category for assessing treatment response in patients with breast cancer?

Author(s):: Vaz, S.C.; Groheux, D.; Nijnatten, T. van; Antunovic, L.; Cardoso, F.; Mottaghy, F.; Cardoso, M.J.; Riedl, C.; Geus-Oei, L.F. de; Ulaner, G.A.

Published: 2024
Publication type: Article / Letter to editor

Date issued: 2024-12-21
Language: English
Is part of: European Journal of Nuclear Medicine and Molecular Imaging (2024), Vol. 52, p. 801-805
hdl: 1887/4209056
doi: 10.1007/s00259-024-07042-9
URL: https://link.springer.com/article/10.1007/s00259-024-07042-9